461 related articles for article (PubMed ID: 17683362)
1. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
2. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Cataland SR; Jin M; Ferketich AK; Kennedy MS; Kraut EH; George JN; Wu HM
Br J Haematol; 2007 Jan; 136(1):146-9. PubMed ID: 17069579
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
[TBL] [Abstract][Full Text] [Related]
5. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
[TBL] [Abstract][Full Text] [Related]
8. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
Cataland SR; Jin M; Lin S; Kraut EH; George JN; Wu HM
Am J Hematol; 2008 Dec; 83(12):911-5. PubMed ID: 18821711
[TBL] [Abstract][Full Text] [Related]
9. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
10. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
11. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
[No Abstract] [Full Text] [Related]
12. Therapeutic modality of 11 patients with TTP in a single institution in Miyazaki from 2000 to 2011.
Kawano N; Yokota-Ikeda N; Yoshida S; Kuriyama T; Yamashita K; Sugio Y; Makino S; Ono N; Inoue Y; Himeji D; Kodama K; Uezono S; Shimao Y; Ueda A; Matsumoto M; Iino H; Fujimura Y
Intern Med; 2013; 52(17):1883-91. PubMed ID: 23994977
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M
Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.
Coppo P; Wolf M; Veyradier A; Bussel A; Malot S; Millot GA; Daubin C; Bordessoule D; Pène F; Mira JP; Heshmati F; Maury E; Guidet B; Boulanger E; Galicier L; Parquet N; Vernant JP; Rondeau E; Azoulay E; Schlemmer B;
Br J Haematol; 2006 Jan; 132(1):66-74. PubMed ID: 16371021
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
16. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
O'Brien KL; Price TH; Howell C; Delaney M
J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
[TBL] [Abstract][Full Text] [Related]
17. Current insight into thrombotic thrombocytopenic purpura.
Verbeke L; Delforge M; Dierickx D
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
[TBL] [Abstract][Full Text] [Related]
18. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
[TBL] [Abstract][Full Text] [Related]
20. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
Chai W; Chaudhry A; Rabinowitz AP
J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
